"Demoged-Forte" veterinary medicinal product in combating ectoparazitosis in dogs and cats
Parasitic arachnoses, through their serious evolution, have anthropozoonotic characters with economic, sanitary and social implications. Infestation with arachnids diminishes considerably the quality of life of domestic animals, causing them metabolic diseases, scratching, stress, allergies and leads to the development of bacterial dermatoses. Fipronil is an acaricidal and stable remedy that lasts longer. The purpose of this study was the control of the efficacy of acaricide of the Demoged-Forte pharmaceutical product in order to combat the ectoparasites in cats and dogs, conditioned by the company Euro Prime Farmaceuticals LLC. The product is very effective in combating sarcoptoses and notoendrosis (98-100 %) in dogs and cats. In the treatment of otodectoses, the product demonstrated an efficacy of 99 %, and in demodicoses was found a result of about 90-92 %. Thus, Demoged-Forte independently, without complexs therap, demonstrated a high efficacy in the treatment of sarcoptoses, notoendrosis, otodectoses and demodicoses, ranging between 92-99 %, which confirms that we can treat animals without putting their lives in danger.
Bourdean P. Variation in size in Demodex canis: from the longest to the shortest forms //Veterinary Dermatologi, 2010, p. 213.
Curtis C. F. Current trends in the treatment of Sarcoptes, Cheyletiella and Otodectes mite infestations in dogs and cats //Veterinary Dermatology. 2004, 15, p. 108-114.
Enciu V. et al. Efectiveness of Ivermectiged 1% to some ecto-and endoparasitosis in sheep. Sustainable use, protection of animal world and forest management in the context of climate change //IX – th international conference of zoologists. Chișinău, 2016, p. 125-126.
Erhan D., Chihai O., Rusu Ş. et. al. Index of the impact and the convalescence of the antiparasitic chemotherapy (Avomec 1%, 2.5% Rombendazol, Tylosinum 200) at infected cattles (S.papillosus, D.lanceolatum). Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca. 2010.- Vol. 67 (2), p. 70-73.
European Convention for the Protection of Vertebrate Animals Used for Experimental and other Scientific Purposes (ETS 123). Strasburg, 1986.
Furie I. I. et al. Comparative eficacy and safety of two tretment regimens with a topically combination of imidacloprid and moxidectin (Advocate) againest generalized demodicosis //Parazitol. Res., 2009, p.15-24.
Mueller R. S. Tratament protocols for demodicosis: an evidence based review //Veterinary Dermatology, 2004, v. 15, p. 75-89.
Paterson T. E. et al. Tratament of canine generalized demodicosis: a blind, randomized clinical trial comparing the efficacy of Advocate Bayer wiht ivermectin. //Veterinary Dermatology, 2009, v. 20, nr.5-6, p. 47-55.
Belova C. Demodecoz u sobak – Demodicosis caninum // VetPharma, 2011, № 5-6, c. 28-33. (in Russian).
Glazunov Yu. V., Stolbova O. A. Effektivnost insecto-akaritsidnysh preparatov veterinarno-sanitarnogo nadzora // Vestnik veterinarii.– 2014, № 2 (69), с. 26-29. (in Russian).
Kolesnikova N. A. Effectivnye skhemy lechenia devodekoza // VetPharma, 2012, №31, c. 56-58. (in Russian).
Ralf C/ Muller. Sarktoptoz, demodekoz i otodektoz u sobak: sposoby lechenia // Jurnal of Small Animal Practice. Российское издание, 2012, том. 3, № 1, с. 50-52. (in Russian).
This work is licensed under a Creative Commons Attribution 4.0 International License.